CSPC Pharmaceutical Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: HK1093012172
HKD
7.66
-0.03 (-0.39%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'16
Sep'16
Jun'16
Mar'16
Dec'15
Sep'15
Jun'15
Net Sales
3,118.66
3,104.52
3,152.53
2,993.34
2,890.77
2,772.58
2,948.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,118.66
3,104.52
3,152.53
2,993.34
2,890.77
2,772.58
2,948.24
Raw Material Cost
1,450.62
1,499.83
1,576.16
1,533.62
1,526.73
1,492.47
1,608.58
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.59
10.91
11.29
10.92
13.58
14.87
16.20
Selling and Distribution Expenses
911.64
859.79
810.85
759.57
738.98
696.91
711.07
Other Expenses
12.49
6.66
9.32
7.67
7.01
5.46
6.90
Total Expenditure (Excl Depreciation)
2,495.71
2,437.15
2,491.51
2,380.86
2,349.42
2,258.86
2,404.85
Operating Profit (PBDIT) excl Other Income
623
667.4
661
612.5
541.4
513.6999999999999
543.4000000000001
Other Income
47.72
-57.81
-86.87
-59.50
0.81
30.11
13.33
Operating Profit (PBDIT)
812.45
835.61
713.52
779.48
705.11
683.56
704.71
Interest
8.59
10.91
11.29
10.92
13.58
14.87
16.20
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
1,668.04
1,604.69
1,576.37
1,459.72
1,364.04
1,280.11
1,339.66
Depreciation
141.78
148.53
139.37
138.84
155.87
139.72
147.99
Profit Before Tax
662.08
676.17
667.36
629.72
535.66
528.97
540.52
Tax
126.39
138.44
136.76
120.52
110.97
104.06
114.83
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
533.09
534.95
527.19
505.62
422.18
421.08
421.69
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
533.09
534.95
527.19
505.62
422.18
421.08
421.69
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.60
2.79
3.41
3.58
2.52
3.83
4.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
535.69
537.73
530.60
509.20
424.70
424.91
425.69
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
10,107.63
0.00
8,950.60
0.00
8,738.06
0.00
0.00
Earnings per share (EPS)
0.05
0.05
0.05
0.04
0.04
0.04
0.04
Diluted Earnings per share
0.05
0.05
0.05
0.04
0.04
0.04
0.04
Operating Profit Margin (Excl OI)
19.97%
23.99%
20.97%
23.39%
18.97%
18.53%
18.43%
Gross Profit Margin
25.78%
26.56%
25.59%
25.68%
23.92%
24.12%
23.35%
PAT Margin
17.09%
17.23%
16.72%
16.89%
14.6%
15.19%
14.3%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2016 is 7.88% vs 2.64% in Dec 2015

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2016 is 26.14% vs 20.79% in Dec 2015

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2016 is 8.58% vs 25.45% in Dec 2015

stock-summary

Interest

YoY Growth in quarter ended Dec 2016 is -36.76% vs 23.64% in Dec 2015

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2016 has improved from Dec 2015

Compare Quarterly Results Of CSPC Pharmaceutical Group Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
3,118.66
0
3,118.66
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,118.66
0
3,118.66
Raw Material Cost
1,450.62
0
1,450.62
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
8.59
0
8.59
Selling and Distribution Expenses
911.64
0
911.64
Other Expenses
12.49
0.00
12.49
Total Expenditure (Excl Depreciation)
2,495.71
0
2,495.71
Operating Profit (PBDIT) excl Other Income
622.95
0.00
622.95
Other Income
47.72
0
47.72
Operating Profit (PBDIT)
812.45
0
812.45
Interest
8.59
0
8.59
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
1,668.04
0
1,668.04
Depreciation
141.78
0
141.78
Profit Before Tax
662.08
0
662.08
Tax
126.39
0
126.39
Provisions and contingencies
0.00
0
0.00
Profit After Tax
533.09
0
533.09
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
533.09
0
533.09
Share in Profit of Associates
0.00
0
0.00
Minority Interest
2.60
0
2.60
Other related items
0.00
0.00
0.00
Consolidated Net Profit
535.69
0
535.69
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
10,107.63
0
10,107.63
Earnings per share (EPS)
0.05
0
0.05
Diluted Earnings per share
0.05
0
0.05
Operating Profit Margin (Excl OI)
19.97%
0%
0.00
19.97%
Gross Profit Margin
25.78%
0%
0.00
25.78%
PAT Margin
17.09%
0%
0.00
17.09%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 311.87 Million
in Dec 2016

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2016 is 0.46% vs -1.52% in Sep 2016

stock-summary

YoY Growth in quarter ended Dec 2016 is 7.88% vs 2.64% in Dec 2015

Quarterly - Consolidate Net Profit
Consolidate Net Profit 53.57 Million
in Dec 2016

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2016 is -0.37% vs 1.34% in Sep 2016

stock-summary

YoY Growth in quarter ended Dec 2016 is 26.14% vs 20.79% in Dec 2015

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 76.47 Million
in Dec 2016

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2016 is -14.41% vs 11.62% in Sep 2016

stock-summary

YoY Growth in quarter ended Dec 2016 is 8.58% vs 25.45% in Dec 2015

Quarterly - Interest
Interest 0.86 Million
in Dec 2016

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2016 is -21.10% vs -3.54% in Sep 2016

stock-summary

YoY Growth in quarter ended Dec 2016 is -36.76% vs 23.64% in Dec 2015

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.97%
in Dec 2016

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2016 has fallen from Sep 2016

stock-summary

YoY Growth in quarter ended Dec 2016 has improved from Dec 2015